Clinical Trial Update: Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents

View source ↗

Summary

A completed clinical trial evaluating cardiovascular risk in patients with severe psoriasis treated with biologic agents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Atopic Dermatitis
• Psoriasis

Snippet

Sponsor: University of Aarhus | Conditions: Psoriasis, Atopic Dermatitis | Status: COMPLETED